Investing.com UK - Financial Markets Worldwide

Genprex Inc (GNPX)

NASDAQ
Symbol
Exchange
Currency
GNPX·NASDAQ·USD
0A8I·London·USD
Currency in USD
2.830
+0.010(+0.35%)
Closed·
After Hours
2.900+0.070(+2.47%)
·

Genprex (GNPX) Price Discussion

$Genprex Inc $GNPX is sitting at $3… with a 52-week high of $63. And a float under 3M. It just bounced off its lowest price in years at $2.61. And while retail ignored it… a US lawmaker quietly bought $15k–$50k worth before the bounce. Stocks with this setup don’t move slowly, they snap. Not calling a moonshot. Just saying this chart looks a lot better before everyone else notices it 👀
$GNPX charts are finally starting to settle. Sellers are still around, but momentum is flattening out across every timeframe. RSI’s stabilising, MACD trying to turn, and we’re building a base around the same zone buyers stepped in last time. Not calling fireworks, but this kind of tightening usually leads to a move. If the ATM pressure eases even a little, this can snap back fast. Eyes on that 3.00 breakout zone.
Pre-market radar locked in. ⚡️ If $GNPX decides to wake up today, it won’t tiptoe… it’ll sprint. Tiny float, fresh 10-Q, Congress money sniffing around, and a chart everyone hates until it doesn’t. Feels like one of those names that can go from “ignored” to “everyone’s FOMO watchlist” in a single session. Let’s see if today’s the day the match gets lit. 🔥🚀 $GNPX
Low float at 668k and just 1.63M shares out make $GNPX a powder keg for a squeeze. Plus, Rep. Tim Moore’s recent $15k-$50k buy screams confidence, and with fresh funding pushing cash runway into 2026 amid ongoing lung cancer trials, we’re set for liftoff. 🚀📈 #GNPX Bullish!
Feels like we’re deep in the grind now. Price keeps sliding, but honestly… a $6.5M market cap with only 1.6M shares in float is just wild. That’s microcap territory for a company still pushing forward with real clinical work. We’re probably hovering around that capitulation zone I’d say $3.60–$3.70 is key support, maybe it dips into the $3.30s if it wants to flush a few more weak hands. But below that? It starts getting silly cheap. If they’d just step up communication a bit even small progress updates, more visibility on socials & sentiment could flip quick. The float’s tiny, so it doesn’t take much for momentum to shift. $4.20 for a bounce, then maybe $4.60–$4.80 if volume returns. I’m just holding and keeping perspective. Most people panic right before the turn.
$GNPX People need to stop focusing only on the day to day dips and look at what’s actually happening behind the scenes. The borrow rate for shorts is sitting ridiculously high 150%+ meaning it’s expensive for anyone betting against this stock to hold their position. That alone tells you supply to short is getting tight. The short interest isn’t huge, but the setup is there if any positive catalyst hits, it could move fast because shorts will want out. Meanwhile, the company is still progressing clinically, and those who’ve been paying attention know that things like this take time. Biotech isn’t a one week play! it’s about milestones and patience. Once the noise around other tickers fades and eyes turn back here, sentiment will shift. High borrow rates, steady progress, and a tight float that’s a combination that usually doesn’t stay quiet forever.
Buy
Buy until 6th of April. Sell then at 6$ or 7$ mark. Drop till 3$ again and buy with a 50% discount :)
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.